期刊文献+

人组织因子基因RNA干扰载体的构建与鉴定 被引量:1

Construction and identification of RNA interference vector for human tissue factor gene
下载PDF
导出
摘要 目的构建人组织因子基因RNA干扰载体,为达到阻止凝血过程的启动打下基础。方法利用Invitrogen公司在线软件设计人组织因子基因(NM_001993)干扰片段,合成shRNA序列,再制备双链寡核苷酸(dsoligo),退火后形成的dsoligo双链克隆到pENTRTM/U6载体的粘性末端,连接产物转化到感受态细胞,增菌,质粒DNA小提、测序。将构建的载体转染到脐静脉内皮细胞,应用RT-PCR和免疫荧光验证载体对目的基因的干扰情况。结果测序证实阳性克隆为pENTRTM/U6-TF-shRNA,转染到脐静脉内皮细胞后组织因子的表达受到明显抑制。结论成功构建出凝血途径的人组织因子基因RNA干扰载体,为研究组织因子基因RNA干扰载体在凝血疾病中的应用提供了稳定的转染细胞载体。 Objective To construct a RNA interference vector for human tissue factor (TF) gene. Methods Human TF short hairpin RNA (shRNA) sequence was designed using online design software (lnvitrogen) and synthesized into double-strand oligonucleotide (ds oligo), which was cloned into the pENTRTM/U6 plasmid, followed by transformation of the product into competent Top 10 E. coli cells. After expansion of the transformed bacteria, the plasmid was extracted and sequenced, which was subsequently transfected into human umbilical vein endothelial cells (HUVECs), The interference effect of the vector on the target gene expression was detected by RT-PCR and immunofluorescence assay, Results The sequencing result indicated that the plasmid pENTRTM/U6-RelB-shRNA was constructed correctly, which resulted in effective inhibition of TF expression in HUVECs after transfection. Conclusion The RNA interference vector against human TF gene has been constructed successfully, which may provide a stable transfection vector for potential treatment of blood coagulation abnormalities.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2007年第7期1065-1067,1070,共4页 Journal of Southern Medical University
关键词 组织因子基因 RNA干扰载体 内皮细胞 human tissue factor gene RNA interference endothelial cells
  • 相关文献

参考文献14

  • 1Schjetlein R,Abdelnoor M,Haugen G,et al.Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia[J].Acta Obstet Gynecol Scand,1999,78 (3):191-7.
  • 2Kuczynski J,Uszynski W,Zekanowska E,et al.Tissue factor (TF)and tissue factor pathway inhibitor (TFPI) in placenta and myometrium[J].Eur J Obstet Gynecol Reprod Biol,2002,105:15-9.
  • 3Holen T,Amarzguioui M,Wiiger MT,et al.Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor[J].Nucleic Acids Res,2002,30 (8):1757-66.
  • 4Reynolds A,Leake D,Boese Q,et al.Rational siRNA design for RNA interference[J].Nat Biotechnol,2004,22 (3):326-30.
  • 5Geley S,Muller C.RNAi:ancient mechanism with a promising future[J].Exp Gerontol,2004,39 (7):985-98.
  • 6Couzin J.Breakthrough of the year.Small RNAs make big splash[J].Science,2002,298 (5602):2296-302.
  • 7de Paula D,Bentley MV,Mahato RI.Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting[J].RNA,2007,13 (4):431-56.
  • 8Scherr M,Morgan MA,Eder M.Gene silencing mediated by small interfering RNAs in mammalian cells[J].Curr Med Chem,2003,10(3):245-56.
  • 9Rana TM.Illuminating the silence:understanding the structure and function of small RNAs[J].Nat Rev Mol Cell Biol,2007,8 (1):23-36.
  • 10Du Q,Thonberg H,Wang J,et al.A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites[J].Nucleic Acids Res,2005,33 (5):1671-7.

同被引文献27

  • 1周北燕,吴香兰,卢光进,韩玉昆.胎盘早剥与前置胎盘高危新生儿的临床特征[J].中华围产医学杂志,2006,9(1):48-50. 被引量:7
  • 2唐雯,杨红玲,冯琼,陶少华,石小东,花少栋,孙学刚,封志纯.胎盘早剥产妇、新生儿血及脐血中组织因子和组织因子途径抑制物的变化[J].中国组织工程研究与临床康复,2007,11(24):4791-4793. 被引量:3
  • 3Cande V, Ananth L, Allen J. Wilcox2 Placental Abruption and Perinatal Mortality in the United States[J]. Am J Epidemiol, 2001, 153(4): 332-7.
  • 4Dafallah SE, Babikir HE. Risk factors predisposing to abruptio placentae. Maternal and fetal outcome[J]. Saudi Med J, 2004, 25 (9): 1237-40.
  • 5Fire A,Xua Q,Montgome MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegants [J]. Nature, 1998, 391(6669): 806-11.
  • 6Tabara H, Grishok A, Mello CC. RNAi in C. elegans: soaking in the genome sequence[J]. Science, 1998, 282(5388): 430-1.
  • 7Geley S, Muller C. RNAi: ancient mechanism with a promising future[J]. Exp Gerontol, 2004, 39(7): 985-98.
  • 8Liu G, Wong-Staal F, Li QX. Development of new RNAi therapeutics[ J ]. Histol Histopathol, 2007, 22.
  • 9Kuczynski J, Uszynski W, Zekanowska E, et al. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in the placenta and myometrium [J]. Eur J Obstet Gynecol Reprod Biol, 2002, 105(1): 15-9.
  • 10Uszynski M, Zekanowska E, Uszynski W, et al. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism[J]. Eur J Obstet Gynecol Reprod Biol, 2001, 95(2): 163.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部